Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.
about
Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@ast
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@en
Predicting therapeutic efficacy of intravenous immunoglobulin
@nl
type
label
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@ast
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@en
Predicting therapeutic efficacy of intravenous immunoglobulin
@nl
prefLabel
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@ast
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@en
Predicting therapeutic efficacy of intravenous immunoglobulin
@nl
P2093
P1476
Predicting therapeutic efficac ...... (RRMS) by functional genomics.
@en
P2093
Birgit Taumberger
Christian Jacobi
Franziska Di Pauli
Gerhard Ransmayr
Judith Haas
Michael Guger
Stefan Meuer
Stefan Wietek
Thomas Berger
Thomas Giese
P304
P356
10.1016/J.JNEUROIM.2014.10.001
P577
2014-10-12T00:00:00Z